Exon definition may facilitate splice site selection in RNAs with multiple exons.

PubWeight™: 8.17‹?› | Rank: Top 0.1%

🔗 View Article (PMC 360715)

Published in Mol Cell Biol on January 01, 1990

Authors

B L Robberson1, G J Cote, S M Berget

Author Affiliations

1: Marrs McClean Department of Biochemistry, Baylor College of Medicine, Houston, Texas 77030.

Articles citing this

(truncated to the top 100)

Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res (2009) 10.08

Splicing regulation: from a parts list of regulatory elements to an integrated splicing code. RNA (2008) 6.29

Splice site prediction in Arabidopsis thaliana pre-mRNA by combining local and global sequence information. Nucleic Acids Res (1996) 6.13

Chromatin organization marks exon-intron structure. Nat Struct Mol Biol (2009) 5.90

Multiple links between transcription and splicing. RNA (2004) 4.90

AT-AC pre-mRNA splicing mechanisms and conservation of minor introns in voltage-gated ion channel genes. Mol Cell Biol (1999) 4.87

Computational definition of sequence motifs governing constitutive exon splicing. Genes Dev (2004) 4.59

SR proteins promote the first specific recognition of Pre-mRNA and are present together with the U1 small nuclear ribonucleoprotein particle in a general splicing enhancer complex. Mol Cell Biol (1994) 4.25

Polypyrimidine tract binding protein antagonizes exon definition. Mol Cell Biol (2001) 4.10

Biased chromatin signatures around polyadenylation sites and exons. Mol Cell (2009) 3.74

The cardiac troponin T alternative exon contains a novel purine-rich positive splicing element. Mol Cell Biol (1993) 3.48

Role of polyadenylation in nucleocytoplasmic transport of mRNA. Mol Cell Biol (1996) 3.26

Impact of alternative initiation, splicing, and termination on the diversity of the mRNA transcripts encoded by the mouse transcriptome. Genome Res (2003) 3.21

G triplets located throughout a class of small vertebrate introns enforce intron borders and regulate splice site selection. Mol Cell Biol (1997) 3.20

A subset of SR proteins activates splicing of the cardiac troponin T alternative exon by direct interactions with an exonic enhancer. Mol Cell Biol (1995) 3.18

Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF. Mol Cell Biol (1993) 3.16

Polypurine sequences within a downstream exon function as a splicing enhancer. Mol Cell Biol (1994) 3.15

Pathways for selection of 5' splice sites by U1 snRNPs and SF2/ASF. EMBO J (1993) 3.11

Translation to near the distal end of the penultimate exon is required for normal levels of spliced triosephosphate isomerase mRNA. Mol Cell Biol (1990) 3.10

Selection of splice sites in pre-mRNAs with short internal exons. Mol Cell Biol (1991) 3.02

Can, a putative oncogene associated with myeloid leukemogenesis, may be activated by fusion of its 3' half to different genes: characterization of the set gene. Mol Cell Biol (1992) 2.99

Effect of 5' splice site mutations on splicing of the preceding intron. Mol Cell Biol (1990) 2.75

Multiple distinct splicing enhancers in the protein-coding sequences of a constitutively spliced pre-mRNA. Mol Cell Biol (1999) 2.72

Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors. Mol Cell Biol (1995) 2.51

Sequences homologous to 5' splice sites are required for the inhibitory activity of papillomavirus late 3' untranslated regions. Mol Cell Biol (1994) 2.49

Sequence information for the splicing of human pre-mRNA identified by support vector machine classification. Genome Res (2003) 2.42

Perturbation of transcription elongation influences the fidelity of internal exon inclusion in Saccharomyces cerevisiae. RNA (2003) 2.36

Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1. Mol Cell Biol (1994) 2.35

Exon and intron sequences, respectively, repress and activate splicing of a fibroblast growth factor receptor 2 alternative exon. Mol Cell Biol (1995) 2.34

Architectural limits on split genes. Proc Natl Acad Sci U S A (1996) 2.29

Intron definition in splicing of small Drosophila introns. Mol Cell Biol (1994) 2.27

The carboxyl terminus of vertebrate poly(A) polymerase interacts with U2AF 65 to couple 3'-end processing and splicing. Genes Dev (2000) 2.27

Selection of novel exon recognition elements from a pool of random sequences. Mol Cell Biol (1995) 2.27

Nuclear pre-mRNA introns: analysis and comparison of intron sequences from Tetrahymena thermophila and other eukaryotes. Nucleic Acids Res (1990) 2.25

Context-dependent control of alternative splicing by RNA-binding proteins. Nat Rev Genet (2014) 2.17

Toward a resolution of the introns early/late debate: only phase zero introns are correlated with the structure of ancient proteins. Proc Natl Acad Sci U S A (1998) 2.16

Sex-lethal autoregulation requires multiple cis-acting elements upstream and downstream of the male exon and appears to depend largely on controlling the use of the male exon 5' splice site. Mol Cell Biol (1993) 2.10

Splicing with inverted order of exons occurs proximal to large introns. EMBO J (1992) 2.10

Intron self-complementarity enforces exon inclusion in a yeast pre-mRNA. Proc Natl Acad Sci U S A (1997) 2.08

Nuclear export and retention signals in the RS domain of SR proteins. Mol Cell Biol (2002) 2.04

Exon inclusion is dependent on predictable exonic splicing enhancers. Mol Cell Biol (2005) 2.02

Molecular basis of the human dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil toxicity. J Clin Invest (1996) 2.02

An intron element modulating 5' splice site selection in the hnRNP A1 pre-mRNA interacts with hnRNP A1. Mol Cell Biol (1997) 2.00

A 32-nucleotide exon-splicing enhancer regulates usage of competing 5' splice sites in a differential internal exon. Mol Cell Biol (1995) 1.92

Insertion of a 5' truncated L1 element into the 3' end of exon 44 of the dystrophin gene resulted in skipping of the exon during splicing in a case of Duchenne muscular dystrophy. J Clin Invest (1993) 1.92

Transcriptional and posttranscriptional regulation of HIV-1 gene expression. Cold Spring Harb Perspect Med (2012) 1.88

Low cytoplasmic mRNA levels of immunoglobulin kappa light chain genes containing nonsense codons correlate with inefficient splicing. EMBO J (1994) 1.87

Order of intron removal during splicing of endogenous adenine phosphoribosyltransferase and dihydrofolate reductase pre-mRNA. Mol Cell Biol (1993) 1.85

Circular RNA is expressed across the eukaryotic tree of life. PLoS One (2014) 1.84

The splicing of U12-type introns can be a rate-limiting step in gene expression. EMBO J (2002) 1.84

Mutations which alter splicing in the human hypoxanthine-guanine phosphoribosyltransferase gene. Nucleic Acids Res (1992) 1.83

Multiple interdependent sequence elements control splicing of a fibroblast growth factor receptor 2 alternative exon. Mol Cell Biol (1997) 1.83

Muscle-specific splicing enhancers regulate inclusion of the cardiac troponin T alternative exon in embryonic skeletal muscle. Mol Cell Biol (1996) 1.81

Antisense-mediated exon skipping: a versatile tool with therapeutic and research applications. RNA (2007) 1.78

Control of calcitonin/calcitonin gene-related peptide pre-mRNA processing by constitutive intron and exon elements. Mol Cell Biol (1993) 1.76

Conserved intron elements repress splicing of a neuron-specific c-src exon in vitro. Mol Cell Biol (1995) 1.75

Human genomic sequences that inhibit splicing. Mol Cell Biol (2000) 1.73

Cooperation of pre-mRNA sequence elements in splice site selection. Mol Cell Biol (1992) 1.70

Regulation of fibronectin EDA exon alternative splicing: possible role of RNA secondary structure for enhancer display. Mol Cell Biol (1999) 1.69

Sequences within the last intron function in RNA 3'-end formation in cultured cells. Mol Cell Biol (1993) 1.67

Intrinsic differences between authentic and cryptic 5' splice sites. Nucleic Acids Res (2003) 1.66

An intronic sequence element mediates both activation and repression of rat fibroblast growth factor receptor 2 pre-mRNA splicing. Mol Cell Biol (1998) 1.64

Rare autosomal recessive cardiac valvular form of Ehlers-Danlos syndrome results from mutations in the COL1A2 gene that activate the nonsense-mediated RNA decay pathway. Am J Hum Genet (2004) 1.63

In vivo recognition of a vertebrate mini-exon as an exon-intron-exon unit. Mol Cell Biol (1993) 1.60

The exon sequence TAGG can inhibit splicing. Nucleic Acids Res (1996) 1.60

Splicing mutants and their second-site suppressors at the dihydrofolate reductase locus in Chinese hamster ovary cells. Mol Cell Biol (1993) 1.58

Modulation of 5' splice site choice in pre-messenger RNA by two distinct steps. Proc Natl Acad Sci U S A (1995) 1.58

Pre-mRNA splicing in the absence of an SR protein RS domain. Genes Dev (2000) 1.58

Direct selection for mutations affecting specific splice sites in a hamster dihydrofolate reductase minigene. Mol Cell Biol (1993) 1.57

Human papillomavirus type 31b late gene expression is regulated through protein kinase C-mediated changes in RNA processing. J Virol (1995) 1.57

Severe deficiency of cystic fibrosis transmembrane conductance regulator messenger RNA carrying nonsense mutations R553X and W1316X in respiratory epithelial cells of patients with cystic fibrosis. J Clin Invest (1991) 1.56

A purine-rich intronic element enhances alternative splicing of thyroid hormone receptor mRNA. RNA (2001) 1.55

Mutations in the conserved loop of human U5 snRNA generate use of novel cryptic 5' splice sites in vivo. EMBO J (1993) 1.55

Human adenovirus encodes two proteins which have opposite effects on accumulation of alternatively spliced mRNAs. Mol Cell Biol (1994) 1.54

Coevolutionary networks of splicing cis-regulatory elements. Proc Natl Acad Sci U S A (2007) 1.54

Elements regulating an alternatively spliced exon of the rat fibronectin gene. Mol Cell Biol (1993) 1.54

Identification of a bidirectional splicing enhancer: differential involvement of SR proteins in 5' or 3' splice site activation. Mol Cell Biol (1999) 1.52

A sequence compilation and comparison of exons that are alternatively spliced in neurons. Nucleic Acids Res (1994) 1.50

Prp5 bridges U1 and U2 snRNPs and enables stable U2 snRNP association with intron RNA. EMBO J (2004) 1.50

Utilization of splicing elements and polyadenylation signal elements in the coupling of polyadenylation and last-intron removal. Mol Cell Biol (1999) 1.48

Participation of the C-terminal domain of RNA polymerase II in exon definition during pre-mRNA splicing. Mol Cell Biol (2000) 1.48

Point mutations in the dystrophin gene. Proc Natl Acad Sci U S A (1992) 1.46

Genomic sequence, splicing, and gene annotation. Am J Hum Genet (2000) 1.46

Splicing in Caenorhabditis elegans does not require an AG at the 3' splice acceptor site. Mol Cell Biol (1993) 1.44

Dichotomous splicing signals in exon flanks. Genome Res (2005) 1.42

Functions of SR proteins in the U12-dependent AT-AC pre-mRNA splicing pathway. RNA (2001) 1.42

RNA splicing at human immunodeficiency virus type 1 3' splice site A2 is regulated by binding of hnRNP A/B proteins to an exonic splicing silencer element. J Virol (2001) 1.41

Simian virus 40 late mRNA leader sequences involved in augmenting mRNA accumulation via multiple mechanisms, including increased polyadenylation efficiency. J Virol (1991) 1.39

Compensatory evolution of a precursor messenger RNA secondary structure in the Drosophila melanogaster Adh gene. Proc Natl Acad Sci U S A (2003) 1.36

Alternative splicing of a human alpha-tropomyosin muscle-specific exon: identification of determining sequences. Mol Cell Biol (1992) 1.36

Regulated immunoglobulin (Ig) RNA processing does not require specific cis-acting sequences: non-Ig RNA can be alternatively processed in B cells and plasma cells. Mol Cell Biol (1994) 1.36

Cross-kingdom patterns of alternative splicing and splice recognition. Genome Biol (2008) 1.36

Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy. Characterization Of cardiac transcript and protein. J Clin Invest (1997) 1.36

A bidirectional SF2/ASF- and SRp40-dependent splicing enhancer regulates human immunodeficiency virus type 1 rev, env, vpu, and nef gene expression. J Virol (2004) 1.35

Evidence for splice site pairing via intron definition in Schizosaccharomyces pombe. Mol Cell Biol (2000) 1.34

Calpainopathy-a survey of mutations and polymorphisms. Am J Hum Genet (1999) 1.31

Effects of nonsense mutations on nuclear and cytoplasmic adenine phosphoribosyltransferase RNA. Mol Cell Biol (1996) 1.31

Consensus sequence Zen. Appl Bioinformatics (2002) 1.31

Influence of intron length on alternative splicing of CD44. Mol Cell Biol (1998) 1.30

Introns in histone genes alter the distribution of 3' ends. Nucleic Acids Res (1990) 1.28

Articles cited by this

Pre-mRNA splicing. Annu Rev Genet (1986) 9.86

A compensatory base change in U1 snRNA suppresses a 5' splice site mutation. Cell (1986) 9.65

The U1 small nuclear RNA-protein complex selectively binds a 5' splice site in vitro. Cell (1983) 9.00

U2 as well as U1 small nuclear ribonucleoproteins are involved in premessenger RNA splicing. Cell (1985) 8.85

Speculations on RNA splicing. Cell (1981) 8.28

The role of small nuclear ribonucleoprotein particles in pre-mRNA splicing. Nature (1987) 8.28

Electrophoretic separation of complexes involved in the splicing of precursors to mRNAs. Cell (1986) 8.06

Splicing of messenger RNA precursors. Science (1987) 7.61

Stepwise assembly of a pre-mRNA splicing complex requires U-snRNPs and specific intron sequences. Cell (1985) 7.49

Interactions between small nuclear ribonucleoprotein particles in formation of spliceosomes. Cell (1987) 7.44

Multiple factors including the small nuclear ribonucleoproteins U1 and U2 are necessary for pre-mRNA splicing in vitro. Cell (1985) 6.85

Evidence for an intron-contained sequence required for the splicing of yeast RNA polymerase II transcripts. Cell (1983) 6.48

Specific transcription and RNA splicing defects in five cloned beta-thalassaemia genes. Nature (1983) 6.48

A role for exon sequences and splice-site proximity in splice-site selection. Cell (1986) 6.41

A multicomponent complex is involved in the splicing of messenger RNA precursors. Cell (1985) 6.27

Recognition of the TACTAAC box during mRNA splicing in yeast involves base pairing to the U2-like snRNA. Cell (1987) 6.08

Spliceosome assembly in yeast. Genes Dev (1987) 6.00

Splice site selection, rate of splicing, and alternative splicing on nascent transcripts. Genes Dev (1988) 5.97

A survey on intron and exon lengths. Nucleic Acids Res (1988) 5.55

A minimal intron length but no specific internal sequence is required for splicing the large rabbit beta-globin intron. Cell (1984) 5.37

Intron sequences involved in lariat formation during pre-mRNA splicing. Cell (1985) 5.30

Electrophoresis of ribonucleoproteins reveals an ordered assembly pathway of yeast splicing complexes. Nature (1987) 5.13

A protein that specifically recognizes the 3' splice site of mammalian pre-mRNA introns is associated with a small nuclear ribonucleoprotein. Cell (1986) 4.57

The 3' splice site of pre-messenger RNA is recognized by a small nuclear ribonucleoprotein. Science (1985) 4.56

An ordered pathway of snRNP binding during mammalian pre-mRNA splicing complex assembly. EMBO J (1987) 4.52

A protein associated with small nuclear ribonucleoprotein particles recognizes the 3' splice site of premessenger RNA. Cell (1986) 4.44

A single-base change at a splice site in a beta 0-thalassemic gene causes abnormal RNA splicing. Cell (1982) 4.22

Alternative splicing caused by RNA secondary structure. Cell (1985) 4.21

An early hierarchic role of U1 small nuclear ribonucleoprotein in spliceosome assembly. Science (1988) 4.16

Affinity chromatography of splicing complexes: U2, U5, and U4 + U6 small nuclear ribonucleoprotein particles in the spliceosome. Science (1986) 4.01

Messenger RNA splicing in vitro: an excised intervening sequence and a potential intermediate. Cell (1984) 4.00

Specific and stable intron-factor interactions are established early during in vitro pre-mRNA splicing. Cell (1985) 3.59

Gel electrophoretic isolation of splicing complexes containing U1 small nuclear ribonucleoprotein particles. Mol Cell Biol (1988) 3.56

mRNA splicing efficiency in yeast and the contribution of nonconserved sequences. Cell (1985) 3.42

Cryptic branch point activation allows accurate in vitro splicing of human beta-globin intron mutants. Cell (1985) 3.25

Multiple interactions between the splicing substrate and small nuclear ribonucleoproteins in spliceosomes. Mol Cell Biol (1987) 3.00

A mutational analysis of spliceosome assembly: evidence for splice site collaboration during spliceosome formation. Genes Dev (1987) 2.99

5' cleavage site in eukaryotic pre-mRNA splicing is determined by the overall 5' splice region, not by the conserved 5' GU. Cell (1987) 2.69

Splice site selection and ribonucleoprotein complex assembly during in vitro pre-mRNA splicing. Genes Dev (1988) 2.62

Alternatives for splicing: recognizing the ends of introns. Cell (1980) 2.59

Signals for the selection of a splice site in pre-mRNA. Computer analysis of splice junction sequences and like sequences. J Mol Biol (1987) 2.54

Trans splicing of mRNA precursors in vitro. Cell (1985) 2.42

A gene chimaera of SV40 and mouse beta-globin is transcribed and properly spliced. Nature (1981) 2.35

The role of nucleotide sequences in splice site selection in eukaryotic pre-messenger RNA. Nature (1987) 2.33

Exon mutations that affect the choice of splice sites used in processing the SV40 late transcripts. Nucleic Acids Res (1985) 2.28

Relationship between the total size of exons and introns in protein-coding genes of higher eukaryotes. Proc Natl Acad Sci U S A (1982) 2.25

Spontaneous splicing mutations at the dihydrofolate reductase locus in Chinese hamster ovary cells. Mol Cell Biol (1986) 2.19

Effect of mutations at the lariat branch acceptor site on beta-globin pre-mRNA splicing in vitro. Nature (1987) 2.11

Preferential excision of the 5' proximal intron from mRNA precursors with two introns as mediated by the cap structure. Proc Natl Acad Sci U S A (1987) 2.04

Evidence against a scanning model of RNA splicing. EMBO J (1983) 2.01

U1 small nuclear ribonucleoproteins are required early during spliceosome assembly. Mol Cell Biol (1987) 1.83

RNA splice site selection: evidence for a 5' leads to 3' scanning model. Science (1983) 1.76

The length of the downstream exon and the substitution of specific sequences affect pre-mRNA splicing in vitro. Mol Cell Biol (1988) 1.69

Different small nuclear ribonucleoprotein particles are involved in different steps of splicing complex formation. Cold Spring Harb Symp Quant Biol (1987) 1.67

Synthetic donor and acceptor splice sites function in an RNA polymerase B (II) transcription unit. EMBO J (1984) 1.66

Evidence for nuclear factors involved in recognition of 5' splice sites. Nucleic Acids Res (1989) 1.58

Antisense RNA inhibits splicing of pre-mRNA in vitro. EMBO J (1988) 1.58

Inhibition of splicing but not cleavage at the 5' splice site by truncating human beta-globin pre-mRNA. Proc Natl Acad Sci U S A (1986) 1.51

Minimal exon sequence requirements for efficient in vitro splicing of mono-intronic nuclear pre-mRNA. J Biol Chem (1987) 1.48

Reversibility of IVS 2 missplicing in a mutant human beta-globin gene. J Biol Chem (1985) 1.40

A role for branchpoints in splicing in vivo. Nature (1985) 1.32

Structural and functional defects in beta-thalassemia. Prog Clin Biol Res (1983) 1.14

Articles by these authors

Spliced segments at the 5' terminus of adenovirus 2 late mRNA. Proc Natl Acad Sci U S A (1977) 14.34

Are U4 small nuclear ribonucleoproteins involved in polyadenylation? Nature (1984) 5.29

Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science (1995) 4.25

Transcription maps of adenovirus. Methods Enzymol (1980) 3.82

In vitro polyadenylation is stimulated by the presence of an upstream intron. Genes Dev (1990) 3.73

Gel electrophoretic isolation of splicing complexes containing U1 small nuclear ribonucleoprotein particles. Mol Cell Biol (1988) 3.56

G triplets located throughout a class of small vertebrate introns enforce intron borders and regulate splice site selection. Mol Cell Biol (1997) 3.20

U1, U2, and U4/U6 small nuclear ribonucleoproteins are required for in vitro splicing but not polyadenylation. Cell (1986) 3.07

Structure of late adenovirus 2 heterogeneous nuclear RNA. J Mol Biol (1979) 2.77

Effect of 5' splice site mutations on splicing of the preceding intron. Mol Cell Biol (1990) 2.75

Mutation of the AAUAAA polyadenylation signal depresses in vitro splicing of proximal but not distal introns. Genes Dev (1991) 2.74

Fractionation and characterization of human small nuclear ribonucleoproteins containing U1 and U2 RNAs. J Biol Chem (1983) 2.45

Architectural limits on split genes. Proc Natl Acad Sci U S A (1996) 2.29

Intron definition in splicing of small Drosophila introns. Mol Cell Biol (1994) 2.27

Dynamic relocation of transcription and splicing factors dependent upon transcriptional activity. EMBO J (1997) 2.27

Regulation of alternative polyadenylation by U1 snRNPs and SRp20. Mol Cell Biol (1998) 2.26

An intron enhancer recognized by splicing factors activates polyadenylation. Genes Dev (1996) 2.08

An intron splicing enhancer containing a G-rich repeat facilitates inclusion of a vertebrate micro-exon. RNA (1996) 2.07

Polypyrimidine tract-binding protein positively regulates inclusion of an alternative 3'-terminal exon. Mol Cell Biol (1999) 2.05

Are vertebrate exons scanned during splice-site selection? Nature (1992) 2.01

A 32-nucleotide exon-splicing enhancer regulates usage of competing 5' splice sites in a differential internal exon. Mol Cell Biol (1995) 1.92

The RNA binding protein YB-1 binds A/C-rich exon enhancers and stimulates splicing of the CD44 alternative exon v4. EMBO J (2001) 1.92

U1 small nuclear ribonucleoproteins are required early during spliceosome assembly. Mol Cell Biol (1987) 1.83

An intronic splicing enhancer binds U1 snRNPs to enhance splicing and select 5' splice sites. Mol Cell Biol (2000) 1.75

An intron enhancer containing a 5' splice site sequence in the human calcitonin/calcitonin gene-related peptide gene. Mol Cell Biol (1995) 1.67

Human U1 and U2 small nuclear ribonucleoproteins contain common and unique polypeptides. Mol Cell Biol (1982) 1.64

In vivo recognition of a vertebrate mini-exon as an exon-intron-exon unit. Mol Cell Biol (1993) 1.60

Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis. Oncogene (1999) 1.60

Evidence for nuclear factors involved in recognition of 5' splice sites. Nucleic Acids Res (1989) 1.58

Participation of the C-terminal domain of RNA polymerase II in exon definition during pre-mRNA splicing. Mol Cell Biol (2000) 1.48

Control of cellular gene expression during adenovirus infection: induction and shut-off of dihydrofolate reductase gene expression by adenovirus type 2. Mol Cell Biol (1983) 1.47

Fibroblast growth factor receptor-1 alpha-exon exclusion and polypyrimidine tract-binding protein in glioblastoma multiforme tumors. Cancer Res (2000) 1.37

Identification of exon sequences and an exon binding protein involved in alternative RNA splicing of calcitonin/CGRP. Nucleic Acids Res (1992) 1.31

A naturally arising mutation of a potential silencer of exon splicing in human immunodeficiency virus type 1 induces dominant aberrant splicing and arrests virus production. J Virol (1997) 1.31

Characterization of single-stranded viral DNA sequences present during replication of adenovirus types 2 and 5. Cell (1976) 1.30

A 5' splice site-proximal enhancer binds SF1 and activates exon bridging of a microexon. Mol Cell Biol (2000) 1.28

Arthritic calcitonin/alpha calcitonin gene-related peptide knockout mice have reduced nociceptive hypersensitivity. Pain (2001) 1.27

Evidence that a nuclear matrix protein participates in premessenger RNA splicing. Exp Cell Res (1989) 1.27

A point mutation inactivating the sulfonylurea receptor causes the severe form of persistent hyperinsulinemic hypoglycemia of infancy in Finland. Diabetes (1999) 1.27

Adenovirus transcription. IV. Synthesis of viral-specific RNA in human cells infected with temperature-sensitive mutants of adenovirus 5. J Virol (1976) 1.25

Adenovirus transcription. III. Mapping of viral RNA sequences in cells productively infected by adenovirus type 5. Virology (1976) 1.23

Direct sequencing of PCR products in agarose gel slices. Nucleic Acids Res (1994) 1.22

Early events after infection of Escherichia coli by bacteriophage T5. Induction of a 5'-nucleotidase activity and excretion of free bases. J Virol (1975) 1.22

Pyrimidine tracts between the 5' splice site and branch point facilitate splicing and recognition of a small Drosophila intron. Mol Cell Biol (1997) 1.16

Relevance of RET proto-oncogene mutations in sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab (1996) 1.15

A role for SRp54 during intron bridging of small introns with pyrimidine tracts upstream of the branch point. Mol Cell Biol (1998) 1.13

Posttranscriptional control of DHFR gene expression during adenovirus 2 infection. J Virol (1985) 1.11

Efficient selection of 3'-terminal exons from vertebrate DNA. Nucleic Acids Res (1993) 1.10

In vitro cleavage of the simian virus 40 early polyadenylation site adjacent to a required downstream TG sequence. Mol Cell Biol (1986) 1.08

A short sequence within two purine-rich enhancers determines 5' splice site specificity. Mol Cell Biol (1998) 1.08

Nuclear-mitotic apparatus protein: a structural protein interface between the nucleoskeleton and RNA splicing. Proc Natl Acad Sci U S A (1994) 1.07

Homozygosity mapping, to chromosome 11p, of the gene for familial persistent hyperinsulinemic hypoglycemia of infancy. Am J Hum Genet (1995) 1.03

Identification of nuclear proteins that specifically bind to RNAs containing 5' splice sites. Proc Natl Acad Sci U S A (1991) 1.01

Inactivation of the first nucleotide-binding fold of the sulfonylurea receptor, and familial persistent hyperinsulinemic hypoglycemia of infancy. Am J Hum Genet (1996) 1.00

Polyadenylation precedes splicing in vitro. Gene Expr (1991) 0.98

UV cross-linking of polypeptides associated with 3'-terminal exons. Mol Cell Biol (1990) 0.98

Role of adenovirus type 2 early region 4 in the early-to-late switch during productive infection. J Virol (1986) 0.98

Calcitonin exon sequences influence alternative RNA processing. Mol Endocrinol (1990) 0.97

Validation of an in vitro RNA processing system for CT/CGRP precursor mRNA. Nucleic Acids Res (1991) 0.97

Multiple endocrine neoplasias. Annu Rev Physiol (2000) 0.94

Surgical strategy for the treatment of medullary thyroid carcinoma. Ann Surg (1999) 0.93

Redundant intronic repressors function to inhibit fibroblast growth factor receptor-1 alpha-exon recognition in glioblastoma cells. J Biol Chem (1999) 0.91

Early events after infection of Escherichia coli by bacteriophage T5. II. Control of the bacteriophage-induced 5'-nucleotidase activity. J Virol (1976) 0.91

The calcitonin exon and its flanking intronic sequences are sufficient for the regulation of human calcitonin/calcitonin gene-related peptide alternative RNA splicing. Mol Endocrinol (1994) 0.91

Transcription of the human calcitonin gene is mediated by a C cell-specific enhancer containing E-box-like elements. Mol Endocrinol (1990) 0.89

Oncogene expression in rat hepatomas and during hepatocarcinogenesis. Cancer Lett (1985) 0.87

Isolation and partial characterization of bacteriophage T5 mutants deficient in the ability to induce deoxynucleoside monophosphate kinase. J Virol (1974) 0.87

Spliced segments at the 5' termini of adenovirus-2 late mRNA: a role for heterogeneous nuclear RNA in mammalian cells. Cold Spring Harb Symp Quant Biol (1978) 0.87

Promiscuity of pre-mRNA spliceosome-mediated trans splicing: a problem for gene therapy? Hum Gene Ther (2001) 0.87

Glioblastoma cell-specific expression of fibroblast growth factor receptor-1beta requires an intronic repressor of RNA splicing. Cancer Res (1999) 0.85

Dexamethasone differentially affects the levels of calcitonin and calcitonin gene-related peptide mRNAs expressed in a human medullary thyroid carcinoma cell line. J Biol Chem (1986) 0.85

Hammerhead ribozyme-mediated inactivation of mutant RET in medullary thyroid carcinoma. Cancer Res (1999) 0.84

Application of genetic screening information to the management of medullary thyroid carcinoma and multiple endocrine neoplasia type 2. Endocrinol Metab Clin North Am (1996) 0.83

A human succinate-ubiquinone oxidoreductase CII-3 subunit gene ending in a polymorphic dinucleotide repeat is located within the sulfonylurea receptor (SUR) gene. Mol Genet Metab (1998) 0.82

Identification of a polymorphism in exon 11 of the RET protooncogene. Hum Mol Genet (1994) 0.82

Isolation and characterization of a bacteriophage T5 mutant deficient in deoxynucleoside 5'-monophosphatase activity. J Virol (1977) 0.82

[Germline mutations of the ret proto-oncogene in Chilean patients with hereditary and sporadic medullary thyroid carcinoma]. Rev Med Chil (2001) 0.82

A codon 891 exon 15 RET proto-oncogene mutation in familial medullary thyroid carcinoma: a detection strategy. Mol Cell Probes (1999) 0.82

Mutational analysis of the GDNF/RET-GDNFR alpha signaling complex in a kindred with vesicoureteral reflux. Hum Genet (1998) 0.80

Screening for MEN1 mutations in patients with atypical endocrine neoplasia. Surgery (1999) 0.80

Dexamethasone inhibits alpha-fetoprotein gene transcription in neonatal rat liver and isolated nuclei. Nucleic Acids Res (1985) 0.80

alpha-Fetoprotein gene DNA-binding proteins. Arch Biochem Biophys (1985) 0.79

Nucleotide sequence at the 5' terminus of adenovirus 2 late messenger RNA. J Biol Chem (1979) 0.79

Exon sequence is required for regulated RNA splicing of the human fibroblast growth factor receptor-1 alpha-exon. J Biol Chem (1998) 0.78

Structure of the mouse calcitonin/calcitonin gene-related peptide alpha and beta genes. DNA Seq (2001) 0.78

Tissue specific control of alpha-fetoprotein gene expression. Biochem Biophys Res Commun (1984) 0.78

The expressions of oncogenes and liver-specific genes in Morris hepatomas. Biochem Biophys Res Commun (1987) 0.78

The molecular basis for familial persistent hyperinsulinemic hypoglycemia of infancy. Proc Assoc Am Physicians (1996) 0.78

Clinical use of molecular information in the management of multiple endocrine neoplasia type 2A. J Intern Med (1995) 0.77

A spliced sequence at the 5'-terminus of adenovirus late mRNA. Brookhaven Symp Biol (1979) 0.76

The enhancement of specific gene transcription in isolated nuclei by added HeLa whole cell extract. Int J Biochem (1984) 0.76

Calcium-induced activation of a mutant G-protein-coupled receptor causes in vitro transformation of NIH/3T3 cells. Neoplasia (1999) 0.75

Spliced segments at the 5' terminus of adenovirus 2 late mRNA. 1977. Rev Med Virol (2000) 0.75

RET protooncogene mutational analysis in multiple endocrine neoplasia syndrome type 2B: case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1996) 0.75

Different mechanisms of calcitonin, calcitonin gene-related peptide, and somatostatin regulation by glucocorticoids in a cell culture of human medullary thyroid carcinoma. Henry Ford Hosp Med J (1987) 0.75

A specific alpha-fetoprotein gene binding protein in alpha-fetoprotein producing rat hepatomas. Biochem Biophys Res Commun (1987) 0.75

1,25-Dihydroxyvitamin D3 silences 3',5'-cyclic adenosine monophosphate enhancement of somatostatin gene transcription in human thyroid C cells. Mol Endocrinol (1989) 0.75

The regulation of somatostatin production in human medullary thyroid carcinoma cells by dexamethasone. J Biol Chem (1986) 0.75

Hepatoma-associated nonhistone chromosomal proteins are present in active chromatin. Mol Cell Biochem (1987) 0.75